# Cellebrite DI Ltd. — Annual Report on Form 20-F for Fiscal Year Ended December 31, 2024 > *Verbatim extracts from Cellebrite DI Ltd.'s most recent 20-F filed with the SEC on 2025-03-18 (SEC accession 0001628280-25-013334). The full filing is 2.95 MB of iXBRL HTML; the extract below captures the Tier-2 facts cited from this filing in the Arkansas Flock wiki.* ## Source metadata - **Publisher:** Cellebrite DI Ltd., filed with the SEC EDGAR system - **URL:** https://www.sec.gov/Archives/edgar/data/1854587/000162828025013334/cele-20241231.htm - **Accession number:** 0001628280-25-013334 - **Filing date:** 2025-03-18 - **Period of report:** 2024-12-31 - **Archived:** 2026-06-05 by `curl` - **Wayback snapshot:** save pending ## Extract — verbatim quotes from the filing ### Corporate history and incorporation > "We were incorporated on April 13, 1999 as a private limited liability company under the laws of the State of Israel. We are registered under the Israeli Companies Law as Cellebrite DI Ltd., and our registration number with the Israeli Registrar of Companies is 51-276657-7." > "Our registered office is currently located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel, which also currently serves as our principal executive offices, and our telephone number is +972-(73) 394-8000." > "The Company was incorporated on April 13, 1999 under Israeli Law and has subsidiaries in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan and India, which are listed below" ### Israeli location and operational footprint > "We are incorporated under Israeli law, and many of our employees, including many of our management members, operate from our principal office and other facilities located in Israel. Furthermore, many of our employees, officers and directors are residents of Israel. We have a small assembly facility in Israel. Accordingly, our business and operations are directly affected by economic, political, geopolitical, and military conditions in Israel and the surrounding region." ### Foreign-private-issuer status > "Although Cellebrite is incorporated and tax resident in Israel, the IRS may assert that it should be treated as a U.S. corporation (and therefore a U.S. tax resident) for U.S. federal income tax purposes pursuant to Section 7874 ('Section 7874') of the Internal Revenue Code of 1986, as amended (the 'Code')." > "As a 'foreign private issuer' under applicable securities laws and regulations, Cellebrite is permitted to, and may, file less or different information with the U.S. Securities and Exchange Commission (the 'SEC') than a company incorporated in the United States, and will follow certain home country governance practices in lieu of certain Nasdaq requirements applicable to U.S. issuers." ### Public listing history (from the executive biographies) > "Mr. Clammer served as the Chief Executive Officer and a Director of TWC Tech Holdings II, LLC, from November 2020 until the consummation of the Merger. Mr. Clammer is also a Founding Partner of True Wind Capital Management, L.P., a private equity fund manager focused on the technology industry. Prior to founding True Wind Capital Management in 2015, Mr. Clammer was with KKR since 1995, where he co-founded and led the Global Technology Group from 2004 to 2013." (This biography establishes that Cellebrite went public on NASDAQ through a merger with the special-purpose acquisition company TWC Tech Holdings II, LLC, advised by Adam Clammer / True Wind Capital. The merger consummated in August 2021; Cellebrite has traded as **NASDAQ: CLBT** since.) ## Notes - Tier: 2 — primary public record (SEC filing by the issuer itself, signed by officers under penalty of SOX § 302 / 906 attestations). - The filing confirms several facts present in the [[CLR-2026-778]] corpus documents: (a) Cellebrite is an Israeli company, not a US-incorporated one (its US sales subsidiary, **Cellebrite Inc.**, of Vienna VA, signs the LRPD customer-facing quotes — see [[Cellebrite Inseyets-UFED Purchase (Carahsoft Quote 49570615)]]); (b) the underlying legal entity for the Endpoint SaaS Terms is **Cellebrite DI Ltd.** as confirmed in [[Cellebrite Advanced Services Agreement]] §14.4. - The full 20-F runs ~200 pages and includes detailed risk factors regarding export controls, geopolitical exposure in the Israeli/Middle East operating environment, and the company's customer concentration in law-enforcement and government markets. Specific risk-factor and Item-4 (Business Overview) deep dives are available in the original `.htm` file. - The 2026-03-03 20-F (accession 0001628280-26-013790) is also available; it covers FY2025 data. Both filings establish identical corporate identity and HQ; the 2024 filing is cited because the LRPD contracting documents in [[CLR-2026-778]] were executed in 2024-2025 and thus fall within the period of report. - Cited by: [[Cellebrite]]